|
Triumph Science & Technology Co., Ltd (600552.SS) Évaluation DCF |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Triumph Science & Technology Co.,Ltd (600552.SS) Bundle
Gagnez la maîtrise de votre science triomphe & Analyse d'évaluation de la technologie Co., Ltd (600552SS) utilisant notre calculatrice DCF de pointe! Ce modèle Excel est préchargé avec des données authentiques (600552SS), vous permettant d'ajuster les prévisions et les hypothèses pour déterminer avec précision Triumph Science & Technology Co., Ltd's Intrinsic Value.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,067.7 | 6,324.2 | 4,623.2 | 5,010.0 | 4,893.8 | 5,716.3 | 6,677.0 | 7,799.1 | 9,109.8 | 10,640.8 |
| Revenue Growth, % | 0 | 24.79 | -26.9 | 8.37 | -2.32 | 16.81 | 16.81 | 16.81 | 16.81 | 16.81 |
| EBITDA | 515.0 | 786.4 | 774.1 | 643.6 | 747.6 | 771.3 | 900.9 | 1,052.3 | 1,229.2 | 1,435.7 |
| EBITDA, % | 10.16 | 12.44 | 16.74 | 12.85 | 15.28 | 13.49 | 13.49 | 13.49 | 13.49 | 13.49 |
| Depreciation | 192.6 | 308.5 | 364.9 | 344.3 | 410.2 | 363.8 | 425.0 | 496.4 | 579.8 | 677.3 |
| Depreciation, % | 3.8 | 4.88 | 7.89 | 6.87 | 8.38 | 6.36 | 6.36 | 6.36 | 6.36 | 6.36 |
| EBIT | 322.4 | 477.9 | 409.2 | 299.3 | 337.4 | 407.4 | 475.9 | 555.9 | 649.3 | 758.5 |
| EBIT, % | 6.36 | 7.56 | 8.85 | 5.97 | 6.89 | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 |
| Total Cash | 856.8 | 639.9 | 1,525.6 | 991.5 | 602.0 | 1,053.1 | 1,230.1 | 1,436.8 | 1,678.3 | 1,960.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,664.2 | 1,614.2 | 1,498.0 | 1,847.5 | .0 | 1,459.3 | 1,704.5 | 1,991.0 | 2,325.6 | 2,716.4 |
| Account Receivables, % | 32.84 | 25.52 | 32.4 | 36.88 | 0.0000000204 | 25.53 | 25.53 | 25.53 | 25.53 | 25.53 |
| Inventories | 1,740.3 | 1,745.7 | 1,918.7 | 2,038.8 | 2,414.2 | 2,211.9 | 2,583.6 | 3,017.8 | 3,525.0 | 4,117.4 |
| Inventories, % | 34.34 | 27.6 | 41.5 | 40.69 | 49.33 | 38.69 | 38.69 | 38.69 | 38.69 | 38.69 |
| Accounts Payable | 679.4 | 1,543.6 | 869.8 | 928.9 | 1,200.1 | 1,139.7 | 1,331.3 | 1,555.0 | 1,816.4 | 2,121.6 |
| Accounts Payable, % | 13.41 | 24.41 | 18.81 | 18.54 | 24.52 | 19.94 | 19.94 | 19.94 | 19.94 | 19.94 |
| Capital Expenditure | -401.9 | -223.4 | -412.9 | -713.0 | -1,012.2 | -632.3 | -738.6 | -862.7 | -1,007.7 | -1,177.0 |
| Capital Expenditure, % | -7.93 | -3.53 | -8.93 | -14.23 | -20.68 | -11.06 | -11.06 | -11.06 | -11.06 | -11.06 |
| Tax Rate, % | 41.69 | 41.69 | 41.69 | 41.69 | 41.69 | 41.69 | 41.69 | 41.69 | 41.69 | 41.69 |
| EBITAT | 289.1 | 364.3 | 333.4 | 158.5 | 196.7 | 292.2 | 341.4 | 398.7 | 465.7 | 544.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,645.3 | 1,358.1 | -445.2 | -620.7 | 1,338.0 | -1,293.5 | -397.7 | -464.5 | -542.6 | -633.8 |
| WACC, % | 5.78 | 5.65 | 5.7 | 5.41 | 5.46 | 5.6 | 5.6 | 5.6 | 5.6 | 5.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2,895.0 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -656 | |||||||||
| Terminal Value | -31,252 | |||||||||
| Present Terminal Value | -23,800 | |||||||||
| Enterprise Value | -26,695 | |||||||||
| Net Debt | 3,151 | |||||||||
| Equity Value | -29,846 | |||||||||
| Diluted Shares Outstanding, MM | 944 | |||||||||
| Equity Value Per Share | -31.60 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-populated financial data for Triumph Science & Technology Co.,Ltd (600552SS).
- Comprehensive Data: Access to historical data and forward-looking predictions (highlighted in the yellow cells).
- Adaptable Forecasting: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Observe the immediate effects of your inputs on the valuation of Triumph Science & Technology Co.,Ltd (600552SS).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Interface: Organized for clarity and ease of use, complete with step-by-step guidance.
Key Features
- Real-Time 600552SS Data: Equipped with Triumph Science & Technology's historical financial data and future projections.
- Completely Customizable Parameters: Modify revenue growth rates, profit margins, WACC, tax rates, and capital expenditure estimates.
- Interactive Valuation Model: Automatically updates Net Present Value (NPV) and intrinsic value based on user inputs.
- Scenario Analysis: Develop multiple forecasting scenarios to evaluate various valuation results.
- Intuitive Interface: Designed with simplicity and structure, suitable for both experts and novices.
How It Works
- Download the Template: Gain immediate access to the Excel-based Triumph Science & Technology DCF Calculator for [600552SS].
- Input Your Assumptions: Modify the yellow-highlighted cells to specify growth rates, WACC, margins, and other variables.
- Instant Calculations: The model will automatically refresh to display the intrinsic value of Triumph Science & Technology.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the insights gained to inform your investment or financial analysis.
Why Choose Triumph Science & Technology Co., Ltd's Calculator?
- Time-Saving: Skip the hassle of building a DCF model from the ground up – it's immediately available for use.
- Enhanced Accuracy: Our dependable financial data and formulas minimize valuation errors.
- Completely Customizable: Adjust the model to align with your specific assumptions and forecasts.
- Simple to Understand: Intuitive charts and outputs make it easy to interpret the results.
- Endorsed by Professionals: Crafted for experts who prioritize accuracy and functionality.
Who Can Benefit from This Product?
- Institutional Investors: Create comprehensive and accurate valuation models for analyzing portfolios, especially for companies like Triumph Science & Technology Co., Ltd (600552SS).
- Corporate Finance Departments: Assess valuation scenarios to inform and shape internal strategies effectively.
- Consultants and Financial Advisors: Equip clients with precise valuation insights regarding Triumph Science & Technology Co., Ltd (600552SS).
- Students and Educators: Utilize real-time data for hands-on practice and teaching in financial modeling.
- Technology Enthusiasts: Gain insights into how tech firms, such as Triumph Science & Technology Co., Ltd (600552SS), are valued in the marketplace.
What the Template Contains
- Historical Data: Provides Triumph Science & Technology’s past financial performance and baseline forecasts.
- DCF and Levered DCF Models: Comprehensive templates to assess the intrinsic value of Triumph Science & Technology.
- WACC Sheet: Pre-defined calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Update crucial parameters such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough overview of Triumph Science & Technology’s financial reports.
- Interactive Dashboard: Dynamically visualize valuation outcomes and projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.